Researchers from the National University of Singapore (NUS) have solved a 60-year-old mystery in bacterial cell envelope ...

Remnants of everything that humans ingest ends up in waste water, including medications that people may be taking, like ...

A Utah State University study found multi-drug resistant bacteria in wastewater, posing a risk of spreading resistance genes.

Flightpath Biosciences, Inc., a clinical stage biotechnology company focused on the development of precision therapeutics targeting bacterial ...

Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya (pivmecillinam ...

Rhubarb could help battle deadly antibiotic-resistant superbugs such as E. coli, suggests new research. Natural compounds ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...

A new study projects that millions of stomach cancer cases globally could be fueled by the Helicobacter pylori bacteria.

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has entered into a licensing agreement ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...